Medigene AG
MDG1
Pozycja w akcjach
#35249
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Cena akcji
$0.14942078
Ostatnia synchronizacja: 2025-05-15
Kapitalizacja rynkowa
$3.86M
Zmiana (1 dzień)
0.10%
Zmiana (1 rok)
47.84%
Kraj
DE
Handel Medigene AG (MDG1)
Kategoria
Healthcare
Historia ceny akcji dla Medigene AG (MDG1)
Najwyższa cena zamknięcia: $0.34 dnia 2025-04-01
Najniższa cena zamknięcia: $61.30 dnia 2007-12-01
Najniższa cena zamknięcia: $61.30 dnia 2007-12-01
Historia cen akcji firmy Medigene AG od 2007 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2025 | -69.63% |
| 2024 | -62.74% |
| 2023 | -33.26% |
| 2022 | -26.38% |
| 2021 | -24.98% |
| 2020 | -21.07% |
| 2019 | -42.42% |
| 2018 | -38.07% |
| 2017 | 37.11% |
| 2016 | 29.60% |
| 2015 | 57.57% |
| 2014 | 2.53% |
| 2013 | -8.47% |
| 2012 | -42.08% |
| 2010 | -54.73% |
| 2009 | -11.17% |
| 2008 | -21.76% |
| 2007 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $534.84 | 25.42% |
US
|
|
| $189.00 | 603.91% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $888.12 | 9.08% |
NL
|
